We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Zerviate

News List

Nicox broadens two agreements with Ocumension in South East Asia pharmaceutical-technology
March 12, 2020
France-headquartered Nicox has expanded two licensing agreements with Chinese Ocumension Therapeutics for two ophthalmology drugs.
Nicox signs agreement for ZERVIATE in South Korea biospectrumasia
December 18, 2019
Samil Pharmaceutical will receive exclusive rights to develop and commercialize ZERVIATE in South Korea, where the market for allergic conjunctivitis was worth nearly €31 million for the 12 months to Q3 2019.
FDA Approves Zerviate drugs.com
June 08, 2017
Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.
FDA Approves Zerviate drugs.com
June 07, 2017
Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%